Skip to search formSkip to main contentSkip to account menu

Xalatan

Known as: Pfizer brand of latanoprost, Xalatan® 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Abstract Purpose: To investigate the corneal toxicity of Xalatan and three latanoprost generics using transepithelial electrical… 
2013
2013
Purpose To compare the intraocular pressure (IOP)-lowering efficacy of Xalatan with the generic latanoprost (Latanoprost EG) in… 
2012
2012
Purpose To determine if a test formulation of latanoprost 0.005% (Bausch & Lomb) eyedrops reduced intraocular pressure (IOP) as… 
2010
2010
Purpose: To compare the efficacy and safety of Xalatan(R) with generic Latanoprost (Xalabiost) in glaucoma. Methods: In this… 
2005
2005
ABSTRACT Purpose: To evaluate the daily cost of antiglaucoma eyedropsand the economic impact related to the minimal wage; to com… 
2004
2004
The prostamide bimatoprost (Lumigan®, Allergan Inc.) has been proven highly effective as monotherapy, adjunctive, and replacement… 
2003
2003
PURPOSE Xalatan treatment has been reported both clinically and experimentally to promote recurrences of herpetic keratitis. Our… 
1999
1999
OBJECTIVE To analyze the hypotensive effect and ocular tolerance produced by the association of a topic carbonic anhidraze…